Researchers at the University of Pennsylvania's Basser Center for BRCA at the Abramson Cancer Center have discovered factors that may make breast and ovarian cancers associated with BRCA1/2 gene mutations more likely to recur.
https://medicalxpress.com/news/2022-11-illuminates-cancers-brca-mutations-recur.html